Tradestie Institutional Equity Comparison Engine
PDX vs USPH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
USPH Overall Edge
USPH Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to US Physical Therapy Inc (USPH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, PDX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus USPH at 29.6x Forward P/E and 10.2% operating margin (+13.1% YoY). In options structure, PDX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against USPH sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
USPH
PDX N/M vs USPH 29.6x Fwd P/E
Growth & Margin Winner
USPH
Op Margin N/A vs 10.2% ยท YoY N/A vs +13.1%
Momentum & Technical Winner
USPH
1Y -7.7% vs +39.8% ยท 52W Pos 42% vs 95%
Options & Structure Winner
USPH
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (<1st %ile IV)
PDX
NYSE
PIMCO Dynamic Income Strategy Fund
Institutional Equity
$20.06
-0.5% 1D
Market Cap
$1.1B
1M Return
+0.2%
1Y Return
-7.69%
Forward P/E
N/M
Unified AI Score
45.3 / 100
HOLD
Tech 41.0
Fund 48.0
Flow 50.0
Mom 50.0
USPH
NYSE
US Physical Therapy Inc
Services-Health Services
$99.55
-0.05% 1D
Market Cap
$1.5B
1M Return
+16.15%
1Y Return
+39.78%
Forward P/E
29.6x
Unified AI Score
31.8 / 100
SELL
Tech 50.0
Fund 25.0
Flow 50.0
Mom 30.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PDX -7.69%
USPH +39.78%
Spread: +47.47 pp (USPH Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
PDX TTM Op. Margin: N/A
USPH TTM Op. Margin: 10.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PDX vs USPH. Trailing 12-month operating profitability (PDX N/A vs USPH 10.2%) and valuation multiples (PDX N/M vs USPH 29.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PDX | USPH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.1B | $1.5B | Larger Scale | USPH |
| Trailing P/E Ratio Valuation | N/M | 32.9x | Lower Multiple | USPH |
| Forward P/E Ratio Valuation | N/M | 29.6x | Lower Multiple | USPH |
| Revenue Growth (YoY) Growth | N/A | +13.1% | Higher Growth | USPH |
| Operating Margin (TTM) Profitability | N/A | 10.2% | Higher Margin | USPH |
| Net Profit Margin Profitability | N/A | 3.6% | Higher Margin | USPH |
| Return on Equity (ROE) Capital Efficiency | N/A | 6.3% | Higher ROE | USPH |
| 52-Week Range Position Momentum | 42% ($18โ$22) | 95% ($58โ$102) | Stronger Trend | USPH |
| Beta / 30D Volatility Risk Regime | 0.19ฮฒ ยท 16% Vol | 0.14ฮฒ ยท 42% Vol | Lower Realized Risk | PDX |
| Unified Institutional Score Composite Signal | 45.3 / 100 (HOLD) | 31.8 / 100 (SELL) | Higher Composite | PDX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PDX vs USPH Buy Guide
PDX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
USPH
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PDX nor USPH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.